XML 55 R36.htm IDEA: XBRL DOCUMENT v3.24.1
SHAREHOLDERS' EQUITY (Tables)
12 Months Ended
Dec. 31, 2023
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]  
Schedule of Number of Reserved and Authorized Shares In Equity Incentive Plans
   
2023
 
       
Share options exercised and outstanding
   
27,963,931
 
RSUs vested and outstanding
   
6,932,439
 
Ordinary shares available for issuance under the Share Option Plans
   
1,116,597
 
         
Total reserved and authorized shares as of December 31, 2023
   
36,012,967
 
Schedule of Stock Option Activity
   
Number of options
   
Weighted-average
exercise price
   
Weighted- average
remaining
contractual term
(in years)
   
Aggregate intrinsic
value
 
                         
Outstanding at January 1, 2023
   
1,958,029
   
$
25.01
     
3.15
   
$
-
 
  Granted
   
331,899
     
17.63
                 
  Exercised
   
(13,552
)
   
20.77
                 
  Expired
   
(228,910
)
   
25.56
                 
  Forfeited
   
(43,527
)
   
26.70
                 
                                 
Outstanding at December 31, 2023
   
2,003,939
   
$
23.70
     
2.77
   
$
152
 
                                 
Exercisable at December 31, 2023
   
1,232,748
   
$
24.60
     
2.05
   
$
-
 
                                 
Vested and expected to vest at December 31, 2023
   
1,983,281
   
$
23.69
     
2.76
   
$
149
 
Schedule of Stock Options Outstanding by Exercise Price Range
December 31, 2023
 
Outstanding
   
Exercisable
 
           
Weighted-
                   
           
average
   
Weighted-
         
Weighted-
 
Ranges of
         
remaining
   
average
         
average
 
exercise
   
Number of
   
contractual
   
exercise
   
Number of
   
exercise
 
price
   
options
   
life (years)
   
price
   
options
   
price
 
                                 
$
15.12-19.75
     
331,899
     
4.62
   
$
17.63
     
-
   
$
-
 
$
22.5-24.89
     
1,280,769
     
1.69
   
$
23.29
     
987,866
   
$
23.32
 
$
25.25-29.1
     
200,149
     
1.82
   
$
27.40
     
134,488
   
$
26.93
 
$
32.71-35.43
     
191,122
     
3.11
   
$
33.06
     
110,394
   
$
32.97
 
                                             
         
2,003,939
                     
1,232,748
   
Schedule of RSU Activity
   
Year ended
December 31,
 
   
2023
 
       
Outstanding at January 1, 2023
   
3,111,206
 
Granted
   
1,390,718
 
Vested
   
(740,398
)
Forfeited
   
(400,491
)
         
Outstanding as of December 31, 2023
   
3,361,035
 
Schedule of Stock-Based Compensation Expense
   
Year ended
December 31,
 
   
2023
   
2022
   
2021
 
                   
Cost of revenues
 
$
515
   
$
399
   
$
236
 
Research and development, net
   
7,709
     
7,215
     
5,412
 
Sales and marketing
   
12,395
     
11,196
     
8,811
 
General and administrative
   
10,531
     
7,286
     
3,115
 
                         
Total expenses
 
$
31,150
   
$
26,096
   
$
17,574
Skyhawk (CNP) Security Ltd. Share Option Plan [Member]  
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]  
Schedule of Stock Option Activity
   
Number of options
   
Weighted-average
exercise price
   
Weighted- average
remaining
contractual term
(in years)
   
Aggregate intrinsic
value
 
                         
Outstanding at January 1, 2023
   
20,341,993
   
$
0.33
     
6.43
     
3,017,612
 
Granted
   
1,428,000
     
0.48
     
-
     
-
 
Exercised
   
-
     
-
     
-
     
-
 
Expired
   
-
     
-
     
-
     
-
 
Forfeited
   
(3,093,688
)
   
0.48
     
-
     
-
 
                                 
Outstanding at December 31, 2023
   
18,676,305
   
$
0.32
     
5.74
     
3,017,612
 
                                 
Exercisable at December 31, 2023
   
2,140,151
   
$
0.01
     
5.69
     
1,005,871
 
                                 
Vested and expected to vest at December 31, 2023
   
18,676,305
   
$
0.32
     
5.74
     
3,017,612
 
Schedule of Stock-Based Compensation Expense
   
Year ended
December 31,
 
   
2023
   
2022
 
Cost of revenues
 
$
-
   
$
-
 
Research and development, net
   
796
     
77
 
Sales and marketing
   
159
     
45
 
General and administrative
   
1,917
     
1,135
 
                 
Total expenses
 
$
2,872
   
$
1,257